NAUT
Nautilus Biotechnology, Inc.
1.96$
+24.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 58.7% | 57.9% | 64.1% | 62.7% | 55.5% | 54.7% | 62.2% | 70.7% | 66.9% | 55.4% | 55.6% | 53.6% | |
| 23.3% | 6.3% | 8.9% | 9.1% | 1.7% | 11.4% | 14.6% | 16.2% | 11.9% | 6.5% | 8.2% | 8.0% | |
| 57.6% | 56.8% | 62.8% | 61.4% | 54.1% | 53.5% | 61.0% | 69.4% | 65.4% | 54.1% | 53.9% | 51.4% | |
| 12.9% | 13.2% | 13.6% | 13.7% | 14.0% | 14.0% | 14.6% | 15.1% | 15.8% | 17.9% | 18.8% | 19.8% | |
| 2.8% | 3.0% | 3.2% | 3.2% | 3.3% | 3.1% | 3.6% | 3.8% | 4.5% | 4.2% | 4.7% | 5.3% | |
| 1.1% | 1.2% | 1.3% | 1.4% | 1.5% | 1.7% | 1.9% | 2.0% | 2.1% | 2.0% | 2.2% | 2.4% | |
| 0.4% | 0.5% | 0.6% | 0.6% | 0.6% | 0.4% | 0.4% | 0.5% | 0.4% | 0.5% | 0.7% | 0.7% | |
| 87.1% | 86.8% | 86.4% | 86.3% | 86.0% | 86.0% | 85.4% | 84.9% | 84.2% | 82.1% | 81.2% | 80.2% | |
| -58.2% | -66.2% | -76.6% | -87.6% | -98.4% | -112.5% | -127.2% | -142.9% | -158.4% | -173.7% | -195.0% | -220.8% | |
| 39.2% | 40.9% | 43.4% | 45.9% | 48.3% | 51.8% | 55.4% | 59.2% | 62.9% | 66.1% | 71.2% | 77.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.